Streetbeat News

Equity Actions

TTD

Investor Business Daily SwingTrader has reportedly purchased stock in The Trade Desk (TTD).

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 2:24 pm

CAT

Investor Business Daily SwingTrader has reportedly purchased Caterpillar Inc. (CAT) stock.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 2:12 pm

RDW

Redwire Corporation (NYSE:RDW) plans to open a new microgravity payload development facility and mission operations center at the Novaparke Innovation & Technology Campus in Floyd County, Indiana. The facility will support increased demand from commercial companies and academic researchers focused on improving pharmaceutical drug development, optimizing disease treatments, and enabling technologies essential for sustainable human spaceflight in low-Earth orbit (LEO) and beyond. Construction is expected to begin in the fourth quarter of this year.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 2:02 pm

AAPL

AMZN

GOOGL

INTC

META

MSFT

NVDA

ORCL

QCOM

SBUX

TSLA

Nasdaq has announced a special rebalance of the Nasdaq 100 on July 24th, an event that has only occurred once before in 2011. The rebalance will not change the securities within the index, but will adjust the weightings of each constituent. The last rebalance in 2011 saw a temporary negative reaction to the index and a reduction in the weightings of Apple, QCOM, and SBUX, while MSFT, ORCL, INTC, and GOOGL saw increases. The upcoming rebalance could potentially impact the 'Magnificent 7' (AAPL, NVDA, MSFT, TSLA, META, GOOGL, AMZN).

Portfolio Pulse from Thrasher Analytics

July 11, 2023 | 1:51 pm

ADCT

ADIL

BTTX

DSS

GDTC

SYTA

US stocks traded mostly higher with the Dow up 0.40% and the NASDAQ up 0.23%. The NFIB Small Business Optimism Index rose to a seven-month high of 91 in June. CytoMed Therapeutics, Adial Pharmaceuticals, and Better Therapeutics saw significant stock increases, while Siyata Mobile, ADC Therapeutics, and DSS, Inc. experienced drops. The US continues to lead in COVID-19 cases and deaths.

Portfolio Pulse from Lisa Levin

July 11, 2023 | 1:48 pm

TMO

Thermo Fisher Scientific Inc. (NYSE:TMO) is currently trading at $516.30, after a 0.11% drop. Over the past month, the stock fell by 1.71%, and in the past year, by 1.06%. The company's price-to-earnings (P/E) ratio is lower than the aggregate P/E of 45.05 of the Life Sciences Tools & Services industry, which could indicate that the stock is undervalued or that shareholders do not expect future growth.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 1:46 pm

CHH

Choice Hotels International Inc (CHH) has provided an update on its strategy and 2023 and 2024 guidance. The company is expanding its franchise business and has exceeded its synergy targets with the integration of Radisson Hotels Americas. CHH has opened 107 hotels in 2023, a 39% increase YoY. The company reiterated its 2023 outlook and expects a 10% YoY growth in adjusted EBITDA for 2024. CHH also repurchased around 1.8 million shares worth over $220 million in H1 2023.

Portfolio Pulse from Lekha Gupta

July 11, 2023 | 1:40 pm

BRTX

BioRestorative Therapies Inc (BRTX) shares dropped by 17.13% after the company announced a $2.1 million registered direct offering. The offering is for the sale of 685,033 shares at $3.03 per share. The proceeds will be used for clinical trials, pre-clinical research and development, and general corporate purposes.

Portfolio Pulse from Henry Khederian

July 11, 2023 | 1:36 pm

IOVA

Iovance Biotherapeutics Inc's shares are trading lower after the company announced the pricing of a public offering of 20 million shares at $7.50 per share, expected to raise approximately $150 million. The proceeds will be used to fund preparations for the commercial launch of lifileucel, support the development of the company's pipeline candidates, and support Proleukin integration activities. Despite the drop, Truist Securities and Chardan Capital analysts reiterated a Buy rating for Iovance, with price targets of $17 and $29 respectively.

Portfolio Pulse from Adam Eckert

July 11, 2023 | 1:30 pm

BGNE

NVS

Beigene and Novartis have mutually agreed to terminate their option agreement to develop, manufacture, and commercialize Ociperlimab, effective immediately.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 1:28 pm